期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

RNA干扰技术逆转P-糖蛋白介导的肿瘤多药耐药研究 被引量：1

原文传递
导出
摘要 P-糖蛋白在多种肿瘤细胞中均有表达，是临床肿瘤耐药的主要原因。RNA认干扰技术可有效降低细胞中P-糖蛋白含量，为解决临床耐药难题带来了希望。本文就该方面研究现状及进展进行综述。
作者 黑虎 房居高
机构地区 首都医科大学附属北京同仁医院耳鼻咽喉头颈外科
出处 《国际耳鼻咽喉头颈外科杂志》 2008年第5期275-278,共4页 International Journal of Otolaryngology-Head and Neck Surgery
关键词 P糖蛋白(P-Glycoprotein) RNA干扰(RNA Interference) 耐药性 肿瘤 (Drug Resistance Neoplasm)
分类号 R730 [医药卫生—肿瘤]
  • 相关文献

参考文献26

  • 1Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim BiophysActa, 1976, 455 (1) : 152-162.
  • 2Stierle V, Laigle A, Jolles B. Modulation of MDR1 gene expression in multidrug resistant MCF7 cells by low concentrations of Small interfering RNAs. Biochem Pharmacol, 2005, 70 (10) : 1424-1430.
  • 3Mickisch GH, Merlino GT, Galski H, et al. Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc Natl AcadSciUSA, 1991, 88 (2) : 547-551.
  • 4Modok S, Mellor HR, Callaghan R. Modulation of multidrug resistance effiux pump activity to overcome chemoresistanee in cancer. CurrOpinPharmaeol, 2006, 6 (4) : 350-354.
  • 5Chi KN, Chia SK, Dixon R, et al. A phase I pharmacokinetie study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer. Invest New Drugs, 2005, 23 (4) : 311-315.
  • 6Pusztai L, Wagner P, Ibrahim N, et al. Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma. Cancer, 2005, 104 (4) : 682-691.
  • 7Hua J, Mutch DG, Herzog TJ. Stable suppression ofMDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line. Gynecol Oncol, 2005, 98 (1) : 31-38.
  • 8Peng Z, Xiao Z, Wang Y, et al. Reversal of P-glycoprotein- mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells. Cancer Gene Ther, 2004, 11 (11):707-712.
  • 9Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411 (6836) : 494-498.
  • 10Brummelkamp TR, Bemards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science, 2002, 296 (5567) : 550-553.

二级参考文献8

  • 1张敏,张新,白春学,陈杰,MinQ.Wei.RNA干扰技术抑制A549细胞表皮生长因子受体表达的研究[J].中华肿瘤杂志,2004,26(12):713-717. 被引量：11
  • 2Bass BL. RNA interference. The short answer. Nature,2001,411 :428-429.
  • 3Nieth C, Priebsch A, Stege A, et al. Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference(RNAi). FEBS Lett, 2003, 545: 144-150.
  • 4Mercier C, Decleves X, Masseguin C, et al. P-glycoprotein(ABCB1) but not multidrug resistance-associated protein 1(ABCC1) is induced by doxorabicin in primary cultures of rat astrocytes. J Neurochem, 2003, 87: 820-830.
  • 5Devroe E, Silver PA. Retrovirus-delivered siRNA. BMC Bioteehnol,2002, 2:15.
  • 6Mello CC, Conte D Jr. Revealing the world of RNA interference.Nature, 2004, 431 : 338-342.
  • 7Sui G, Soohoo C, Affar el B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA, 2002, 99: 5515-5520.
  • 8杨晓葵,邢辉,高庆蕾,王薇,邬素芳,卢运萍,王世宣,马丁.mdr-1特异性核酶逆转卵巢癌的多药耐药[J].中华肿瘤杂志,2003,25(5):425-428. 被引量：10

共引文献18

同被引文献75

  • 1ESCALANTE A A, SMITH D L, KIM Y. The dynamics of mutations associated with anti-malarial drug resistance in P lasmodiumfalci parurn [ J ]. Trends Parasitol , 2009,25 ( 12 ) 557-563.
  • 2LEGARE D, CAYER S,SINGH A K,et al. ABC proteins in Leishmania[J]. J Bioenerg Biomembr, 2001,33 (6) : 469 474.
  • 3LEANDRO C,CAMPINO L. Leishmaniasis: efflux pumps and chemoresistance[J]. Int J Antimicrob Agents, 2003,22 (3) : 352-357.
  • 4MASER P, LU SCHER A, KAMINSKY R. Drug transport and drug resistance in African trypanosomes[J]. Drug Res Updates ,2003,6(5) :281-290.
  • 5JACKSON F, COOP R L. The development of anthelmintic resistance in sheep nematodes [J]. Parasitology, 2000, 120 (7) :95-107.
  • 6KOHLER P. The biochemical basis of anthelmintic action and resistance[J]. Int J Parasitol,2001,31( 4) :336 -345.
  • 7OUELLETTE M. Biochemical and molecular mechanisms of drug resistance in parasites[J]. Trop Med Int Health,2001 ,(5 (2) :874-882.
  • 8KERBOEUF D, BLACKHALL W, KAMINSKY R, et al. P glycoprotein in helminths: function and perspectives for anthel mintic treatment and reversal of resistance[J], Int J Antimicrob Agents,2003,22(3) : 332-346.
  • 9JULIANO R L, LING V. A surface glycoprotein modulating drug permeabilily in Chinese hamster ovary cell mutants[J]. Biochim Biophys Acta ,1976,455(1) :152-162.
  • 10JONES P M,GEORGE A M. Multidrug resistance in parasites: ABC transporters, P glycoproteins and molecular mo deling[J]. Int J Parasitol,2005,35(5):555-566.

引证文献1

二级引证文献5

国际耳鼻咽喉头颈外科杂志
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部